AAAAAA

   
Results: 1-3 |
Results: 3
PHASE-II TRIAL OF URACIL TEGAFUR (UFT) PLUS LEUCOVORIN IN PATIENTS WITH ADVANCED PANCREATIC-CARCINOMA - A UNIVERSITY-OF-CHICAGO PHASE-II CONSORTIUM STUDY/
Authors: MANI S KUGLER JW SCIORTINO DF GARCIA JC ANSARI RH HUMERICKHOUSE R MICHELASSI F POSNER MC SHULMAN KL SCHILSKY RL LIST M VOKES EE BENNER S
Citation: S. Mani et al., PHASE-II TRIAL OF URACIL TEGAFUR (UFT) PLUS LEUCOVORIN IN PATIENTS WITH ADVANCED PANCREATIC-CARCINOMA - A UNIVERSITY-OF-CHICAGO PHASE-II CONSORTIUM STUDY/, Annals of oncology, 9(9), 1998, pp. 1035-1037
PHASE-I STUDY OF THE DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) INHIBITOR ENILURACIL (GW776C85) AND ORAL 5-FU WITH CONCOMITANT RADIOTHERAPY (XRT) FOR RECURRENT OR ADVANCED HEAD AND NECK-CANCER (HNC)
Authors: VOKES EE HUMERICKHOUSE R DOLAN E BROCKSTEIN B HARAF D STENSON K KIES M SULZEN L HOUSE L RATAIN MJ
Citation: Ee. Vokes et al., PHASE-I STUDY OF THE DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) INHIBITOR ENILURACIL (GW776C85) AND ORAL 5-FU WITH CONCOMITANT RADIOTHERAPY (XRT) FOR RECURRENT OR ADVANCED HEAD AND NECK-CANCER (HNC), Annals of oncology, 9, 1998, pp. 597-597
ORAL 5-FU ALTERNATIVES FOR THE TREATMENT OF HEAD AND NECK-CANCER
Authors: VOKES EE BROCKSTEIN BE HUMERICKHOUSE R HARAF DJ
Citation: Ee. Vokes et al., ORAL 5-FU ALTERNATIVES FOR THE TREATMENT OF HEAD AND NECK-CANCER, Oncology, 12(10), 1998, pp. 35-38
Risultati: 1-3 |